Loading component...
Experience
Samantha provides consulting services to insurance companies, pharmacy benefit managers, Medicare plan sponsors, government entities, and nonprofit organizations.
Her primary work includes assisting Medicare Part D plan sponsors and other groups with strategic decisions around prescription drug plan pricing within the context of the current regulatory environment.
Publications and Presentations
- Co-author, Possible outcomes of potential disclosure requirements in Medicare Part D. Milliman White Paper, March 2023.
- Co-author, Self-reported health status of Medicare Part D beneficiaries. Millman Research Paper, November 2022.
- Co-author, Is Build Back Better Back? Overview of New Schumer Drug Pricing Reform. Milliman Briefing Note, July 2022.
- Co-author, A summary of insulin coverage in Medicare Part D. Milliman Report, June 2022.
- Co-author, Medicare Part D pharmacy price concessions at the point of sale. Milliman Report, February 2022.
- Co-author, A regulatory push to lower Part D costs at the pharmacy counter in 2023. Milliman Report, January 2022.
- Co-author, A demographic profile of Medicare Part D beneficiaries. Milliman White Paper, November 2021.
- Co-author, Reducing insulin costs for seniors: Thoughts for plan sponsors considering participation in the Medicare Part D Senior Savings Model. Milliman White Paper, March 2020.
- Co-author, A new Part D benefit design? Prescription Drug Pricing Reduction Act proposes major changes to Part D. Milliman White Paper, August 2019.
Education
- BA, Summa Cum Laude, Major: Psychology, Research Track, Minor: Neuroscience; University of Connecticut
- MA, Behavioral Neuroscience, University of Connecticut
- PhD, Behavioral Neuroscience, University of Connecticut
